TipRanks
Advertisement
Advertisement

TXMD Stock Latest News

TherapeuticsMD Q2 Results and Strategic Alternatives Review
Company AnnouncementsTherapeuticsMD Q2 Results and Strategic Alternatives Review
2M ago
8K
TXMD
TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year
PremiumThe Fly
TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year
5M ago
TXMD
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
PremiumCompany Announcements
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
5M ago
8K
TXMD
TherapeuticsMD Explains Brief Delay In Annual Filing
PremiumCompany Announcements
TherapeuticsMD Explains Brief Delay In Annual Filing
6M ago
TXMD
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
PremiumCompany Announcements
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
6M ago
8K
TXMD
TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
PremiumThe FlyTherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
6M ago
TXMD
TherapeuticsMD Approves Key Proposals at Annual Meeting
Premium
Company Announcements
TherapeuticsMD Approves Key Proposals at Annual Meeting
10M ago
8K
TXMD
TherapeuticsMD Reports Q3 2025 Financial Results
Premium
Company Announcements
TherapeuticsMD Reports Q3 2025 Financial Results
11M ago
8K
TXMD
TherapeuticsMD reports Q3 EPS 0c vs. (5c) last year
PremiumThe Fly
TherapeuticsMD reports Q3 EPS 0c vs. (5c) last year
11M ago
TXMD
TherapeuticsMD Reports Improved Q2 2025 Results
PremiumCompany Announcements
TherapeuticsMD Reports Improved Q2 2025 Results
1y ago
TXMD
TherapeuticsMD Reports Q2 2025 Financial Results
PremiumCompany Announcements
TherapeuticsMD Reports Q2 2025 Financial Results
1y ago
8K
TXMD
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
PremiumThe Fly
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
1y ago
TXMD
TherapeuticsMD Reports Improved Q1 2025 Results
PremiumCompany AnnouncementsTherapeuticsMD Reports Improved Q1 2025 Results
1y ago
TXMD
TherapeuticsMD Reports Q1 2025 Financial Results
Premium
Company Announcements
TherapeuticsMD Reports Q1 2025 Financial Results
1y ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
Premium
The Fly
TherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
1y ago
TXMD
TherapeuticsMD Reports Improved Financial Performance
PremiumCompany Announcements
TherapeuticsMD Reports Improved Financial Performance
2y ago
TXMD
TherapeuticsMD Reports Reduced Losses and Revenue Growth
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses and Revenue Growth
2y ago
8K
TXMD
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
2y ago
TXMD
TherapeuticsMD Shifts Focus with Lower Q3 Losses
PremiumCompany Announcements
TherapeuticsMD Shifts Focus with Lower Q3 Losses
2y ago
8K
TXMD
TherapeuticsMD Releases Preliminary Quarterly Financial Results
PremiumCompany AnnouncementsTherapeuticsMD Releases Preliminary Quarterly Financial Results
2y ago
8K
TXMD
TherapeuticsMD Releases Preliminary Q1 2024 Financials
Premium
Company Announcements
TherapeuticsMD Releases Preliminary Q1 2024 Financials
2y ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
Premium
The Fly
TherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
2y ago
TXMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >